- Home
- CASI vs WYY Comparison
CASI vs WYY Comparison
Compare CASI & WYY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CASI
- WYY
- Stock Information
- Founded
- CASI 1991
- WYY 1991
- Country
- CASI China
- WYY United States
- Employees
- CASI N/A
- WYY N/A
- Industry
- CASI Biotechnology: Pharmaceutical Preparations
- WYY EDP Services
- Sector
- CASI Health Care
- WYY Technology
- Exchange
- CASI Nasdaq
- WYY Nasdaq
- Market Cap
- CASI 58.8M
- WYY 54.9M
- IPO Year
- CASI 1996
- WYY 1998
- Fundamental
- Price
- CASI $3.09
- WYY $4.82
- Analyst Decision
- CASI Strong Buy
- WYY Strong Buy
- Analyst Count
- CASI 1
- WYY 1
- Target Price
- CASI $6.00
- WYY $7.00
- AVG Volume (30 Days)
- CASI 56.2K
- WYY 123.8K
- Earning Date
- CASI 11-15-2024
- WYY 11-13-2024
- Dividend Yield
- CASI N/A
- WYY N/A
- EPS Growth
- CASI N/A
- WYY N/A
- EPS
- CASI N/A
- WYY N/A
- Revenue
- CASI $22,055,000.00
- WYY $133,124,648.00
- Revenue This Year
- CASI N/A
- WYY $25.94
- Revenue Next Year
- CASI $134.79
- WYY $13.22
- P/E Ratio
- CASI N/A
- WYY N/A
- Revenue Growth
- CASI N/A
- WYY 31.67
- 52 Week Low
- CASI $2.05
- WYY $1.83
- 52 Week High
- CASI $8.19
- WYY $6.25
- Technical
- Relative Strength Index (RSI)
- CASI 39.70
- WYY 49.83
- Support Level
- CASI $2.50
- WYY $3.88
- Resistance Level
- CASI $3.47
- WYY $4.93
- Average True Range (ATR)
- CASI 0.43
- WYY 0.48
- MACD
- CASI 0.07
- WYY -0.12
- Stochastic Oscillator
- CASI 39.80
- WYY 39.66
About CASI CASI Pharmaceuticals Inc.
CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. The company products include CID-103, CNCT19, EVOMELA, MARQIBO, ZEVALIN, ENMD-2076 and others. The majority of the revenue is generated from the product sales of EVOMELA.
About WYY WidePoint Corporation
WidePoint Corp is a provider of Technology Management as a Service (TMaaS) that consists of federally certified communications management, identity management, interactive bill presentment and analytics, and Information Technology as a Service solution. Its solutions include Telecom Lifecycle Management, Digital billing communications solutions, and Mobile and Identity management. Geographically the company generates a majority of its revenue from the United States and rest from Europe.